First brain cancer day: All mobilized against the 2nd cause of cancer in young adults

First brain cancer day All mobilized against the 2nd cause

  • News
  • Published on
    Updated


    Reading 2 min.

    Five patient associations are behind the very first national brain cancer day in France. The objective of this launch is twofold: to bring together all patients who suffer from this pathology, in its different forms, and to raise awareness among the general public, health professionals and the political world.

    L’Association for Research on Brain Tumors (ARTC)L’ARTC South, Oligocyte West Brittany, Stars In The Sea-Overcoming GlioblastomaAnd More cerebral than us tumor : here are the five associations which have joined forces to create the very first national brain cancer day, which will be held on December 7, 2023.

    Uniting patients and raising awareness among the general public

    The objectives of this day are both to unite patients affected by the same disease, but also to raise awareness among the general public about this little-known pathology, without forgetting health actors and political decision-makers.

    Awareness-raising actions will therefore take place throughout France in order to better understand brain tumors. Three round tables organized in Paris and broadcast live on Youtube around the theme “How to improve the lives of patients with brain cancer” will provide an update on these different types of cancers which affect thousands of French people: https://www.youtube.com/watch?v=QaLARRgpXMs

    Advancing treatments

    Unlike other types of cancer, brain tumors affect all age groups and are the second leading cause of cancer in young adults. Gliomas, which account for 30% of cases of primary brain tumors and notably include glioblastomas, represent the most common aggressive brain tumor in adults. However, treatments for brain cancer currently remain particularly difficult, for four reasons:

    • The location of these tumors, which complicates surgery;
    • The blood-brain barrier responsible for protecting the brain, which prevents effective penetration of anti-cancer drugs;
    • The fragility of brain tissue in the face of radiotherapy;
    • Resistance of tumors to chemotherapy and radiotherapy.

    “Faced with these diseases, it is important to highlight the many advances that have already been made and the promising clinical trials underway. Remaining positive in these challenges and continuing to support research gives hope to patients and to their loved ones” recalled Amandine Cornille, Vice-President of More cerebral than us, tumor. “It is in this state of mind that this National Brain Cancer Day also falls.”

    Many avenues of research are being explored

    Research plays a key role in improving the care of patients with brain cancer, while therapeutic solutions are lacking.” said Monique Haillant, member of the board of directors of the Association for Research on Brain Tumors-ARTC. “This Day will be an opportunity to highlight current research avenues in brain cancers and to allow researchers to express their needs. It will also raise awareness among public authorities to facilitate patient access to innovations and supportive care as well as to stimulate research in areas that are still insufficiently supported, such as the search for disease risk factors.“.

    To find out more about the latest advances in research against these formidable cancers, discover our articles:


    dts1